Meridian bioscience inc (VIVO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Jun'09
NET REVENUES

57,296

47,421

50,846

48,440

50,248

51,480

53,100

51,737

56,451

52,283

49,697

50,140

54,125

46,809

46,998

50,665

51,259

47,160

47,068

48,204

51,545

48,013

46,692

47,212

50,134

44,794

48,962

47,108

47,265

45,351

43,483

41,915

47,239

40,075

40,462

40,052

41,059

37,263

35,539

33,857

31,147

42,457

38,240

COST OF SALES

22,842

19,981

21,690

20,181

20,910

19,908

20,944

19,775

21,882

20,273

19,067

18,994

20,648

17,770

17,850

17,756

17,687

15,577

17,275

17,873

19,024

18,776

18,291

17,970

18,541

16,787

18,088

16,477

16,522

16,555

15,942

14,498

17,691

15,533

16,352

14,701

15,102

13,761

14,205

12,121

11,006

16,972

14,917

GROSS PROFIT

34,454

27,440

29,156

28,259

29,338

31,572

32,156

31,962

34,569

32,010

30,630

31,146

33,477

29,039

29,148

32,909

33,572

31,583

29,793

30,331

32,521

29,237

28,401

29,242

31,593

28,007

30,874

30,631

30,743

28,796

27,541

27,417

29,548

24,542

23,601

25,351

25,957

23,502

21,334

21,736

20,141

25,485

23,323

OPERATING EXPENSES
Research and development

5,386

4,824

5,571

4,594

3,816

3,967

3,614

4,264

4,491

4,420

4,524

3,964

3,951

3,597

4,135

3,546

3,129

3,381

2,920

3,214

3,368

3,103

3,367

3,146

3,186

2,853

2,748

2,711

2,811

2,517

2,834

2,660

2,508

2,273

2,494

2,693

2,326

2,309

1,853

2,128

2,337

2,078

1,958

Selling and marketing

6,514

6,684

7,225

6,747

6,911

7,563

8,475

8,502

8,647

8,844

8,743

7,961

8,066

7,618

8,318

8,085

7,210

6,443

6,856

6,184

6,481

6,080

6,222

6,249

6,461

5,978

5,820

5,440

5,471

5,693

5,519

5,617

5,579

5,377

4,844

5,968

5,598

5,475

4,720

4,287

4,356

4,887

4,509

General and administrative

10,480

8,756

8,710

8,002

7,388

8,902

8,381

8,380

8,842

9,202

7,794

8,289

7,274

7,739

6,844

7,537

6,875

8,173

6,756

6,535

6,940

7,385

6,844

6,715

6,280

7,550

9,035

6,781

7,208

7,495

7,136

6,162

6,431

6,643

5,865

6,559

5,831

6,628

5,713

4,872

4,323

4,764

4,325

Acquisition-related costs

1,787

-

-

473

885

-

-

-

-

-

-

-

-

-

-

-

1,202

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration obligation

-2,491

1,187

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition and restructuring costs

-

-

-

-

-

-

-

-

3,458

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring costs

252

275

-

1,801

-100

-

-

913

-

734

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selected legal costs

735

320

213

178

603

589

975

1,168

1,453

749

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill impairment charge

-

-

-

-

-

-

-

-

-

-

-

6,628

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and marketing leadership reorganization costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,240

-

-

-

0

-

-

Plant consolidation costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

366

203

444

-

-

-

-

-

-

-

-

-

Bioline Group transaction costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

673

-

-

0

Total operating expenses

22,663

22,046

23,307

21,795

19,503

21,021

25,046

23,227

26,891

23,949

21,823

26,842

19,291

18,954

20,253

19,168

18,416

17,997

16,532

15,933

16,789

16,568

16,433

16,110

15,927

16,381

17,603

14,932

15,490

15,705

15,489

14,805

14,721

14,737

13,751

15,220

14,995

14,412

12,853

11,960

11,016

11,729

10,792

OPERATING INCOME

11,791

5,394

5,849

6,464

9,835

10,551

7,110

8,735

7,678

8,061

8,807

4,304

14,186

10,085

8,895

13,741

15,156

13,586

13,261

14,398

15,732

12,669

11,968

13,132

15,666

11,626

13,271

15,699

15,253

13,091

12,052

12,612

14,827

9,805

9,850

10,131

10,962

9,090

8,481

9,776

9,125

13,756

12,531

OTHER INCOME (EXPENSE)
Interest income

23

111

134

194

204

149

147

109

90

72

69

51

29

22

25

22

3

17

5

6

6

6

10

5

6

4

6

12

19

7

15

14

8

5

45

26

27

17

34

29

30

31

54

Interest expense

532

767

787

448

347

363

371

375

379

395

404

407

408

423

-

427

43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

1,365

-712

160

268

-445

139

-8

151

-165

-80

162

-2

383

-25

259

65

-324

96

-128

-99

-211

-582

196

-257

-28

-220

-221

-160

257

128

74

31

-43

316

-5

36

118

203

155

-9

110

-118

129

Total other income (expense)

856

-1,368

-493

14

-588

-75

-232

-115

-454

-403

-173

-358

4

-426

-143

-340

-364

113

-123

-93

-205

-576

206

-252

-22

-216

-215

-148

276

135

89

45

-35

321

40

62

145

220

189

20

140

-87

183

EARNINGS BEFORE INCOME TAXES

12,647

4,026

5,356

6,478

9,247

10,476

6,878

8,620

7,224

7,658

8,634

3,946

14,190

9,659

8,752

13,401

14,792

13,699

13,138

14,305

15,527

12,093

12,174

12,880

15,644

11,410

13,056

15,551

15,529

13,226

12,141

12,657

14,792

10,126

9,890

10,193

11,107

9,310

8,670

9,796

9,265

13,669

12,714

INCOME TAX PROVISION

3,288

1,199

1,253

1,399

2,153

2,370

1,444

1,795

1,936

1,356

2,908

3,706

4,878

3,380

3,261

4,647

5,701

4,806

4,671

5,203

5,457

4,192

3,992

4,045

5,344

3,984

3,906

5,392

5,280

4,752

3,568

4,063

5,166

3,548

3,180

3,357

3,847

3,285

3,348

3,372

3,285

4,748

4,212

NET EARNINGS

9,359

2,827

4,103

5,079

7,094

8,106

5,434

6,825

5,288

6,302

5,726

240

9,312

6,279

5,491

8,754

9,091

8,893

8,467

9,102

10,070

7,901

8,182

8,835

10,300

7,426

9,150

10,159

10,249

8,474

8,573

8,594

9,626

6,578

6,710

6,836

7,260

6,025

5,322

6,424

5,980

8,921

8,502

Earnings Per Share Data:
BASIC EARNINGS PER COMMON SHARE

0.22

0.07

0.09

0.12

0.17

0.19

0.13

0.16

0.12

0.15

0.13

0.01

0.22

0.15

0.13

0.21

0.22

0.21

0.20

0.22

0.24

0.19

0.20

0.21

0.25

0.18

0.21

0.25

0.25

0.21

0.21

0.21

0.23

0.16

0.16

0.17

0.18

0.15

0.13

0.16

0.15

0.22

0.21

DILUTED EARNINGS PER COMMON SHARE

0.22

0.07

0.09

0.12

0.17

0.19

0.13

0.16

0.12

0.15

0.13

0.01

0.22

0.15

0.13

0.21

0.21

0.21

0.20

0.22

0.24

0.19

0.20

0.21

0.24

0.18

0.23

0.24

0.24

0.20

0.20

0.21

0.23

0.16

0.15

0.17

0.18

0.15

0.12

0.16

0.15

0.22

0.21

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING -BASIC

42,830

42,789

42,703

42,639

42,496

42,446

42,365

42,349

42,323

42,263

42,188

42,203

42,202

42,159

41,964

42,076

42,053

41,947

41,608

41,714

41,707

41,607

41,463

41,478

41,471

41,408

41,186

41,304

41,266

41,148

41,082

41,091

41,080

41,067

40,822

40,737

40,686

40,615

40,515

40,535

40,514

40,496

40,500

EFFECT OF DILUTIVE STOCK OPTIONS AND RESTRICTED SHARE UNITS

138

149

132

271

450

459

499

409

409

399

400

390

366

376

393

387

372

380

358

379

341

334

-153

618

676

691

712

679

681

604

559

593

540

420

574

657

662

679

568

616

663

689

691

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED

42,968

42,938

42,835

42,910

42,946

42,905

42,864

42,758

42,732

42,662

42,588

42,593

42,568

42,535

42,357

42,463

42,425

42,327

41,966

42,093

42,048

41,941

41,310

42,096

42,147

42,099

41,898

41,983

41,947

41,752

41,641

41,684

41,620

41,487

41,396

41,394

41,348

41,294

41,083

41,151

41,177

41,185

41,191

ANTI-DILUTIVE SECURITIES:
Common share options and restricted share units

1,635

1,407

1,846

1,215

771

684

978

995

1,021

1,034

915

861

1,001

715

489

465

444

450

575

493

570

566

473

337

168

110

204

256

262

294

308

313

316

343

233

160

211

160

278

234

215

141

150

DIVIDENDS DECLARED PER COMMON SHARE

-

-

0.00

0.00

0.12

0.12

0.12

0.12

0.12

0.12

0.12

0.12

0.12

0.20

0.20

0.20

0.20

0.20

0.20

0.20

0.20

0.20

0.20

0.20

0.20

0.19

0.19

0.19

0.00

0.38

0.19

0.19

0.19

0.19

0.19

0.19

0.19

0.19

0.19

0.19

0.19

0.17

0.17